tumor-infiltrating immune cells are present in GIST and seem to be associated with disease outcomes and also with increasing the activity of imatinib”
Indio, V., Astolfi, A., Urbini, M., Nannini, M., Pantaleo, M.A. (2020). Genetics and treatment of gastrointestinal stromal tumors with immune checkpoint inhibitors: what do we know?. PHARMACOGENOMICS, 2019-0173, 2019-0173-2019-0173 [10.2217/pgs-2019-0173].
Genetics and treatment of gastrointestinal stromal tumors with immune checkpoint inhibitors: what do we know?
Indio, Valentina;Astolfi, Annalisa;Urbini, Milena;Nannini, Margherita;Pantaleo, Maria A
2020
Abstract
tumor-infiltrating immune cells are present in GIST and seem to be associated with disease outcomes and also with increasing the activity of imatinib”File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.